MERS-CoV Nucleocapsid Produkte
(MERS-Coronavirus Nucleocapsid Protein (MERS-CoV N))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene MERS-CoV Nucleocapsid Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
WB
Validierungen
Kat. Nr.
ABIN7383849
Menge
50 μL
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
ELISA, WB
Validierungen
Kat. Nr.
ABIN7383848
Menge
50 μL
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Applikation
ELISA, WB
Validierungen
Kat. Nr.
ABIN7383850
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene MERS-CoV Nucleocapsid Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Source
Baculovirus infected Insect Cells
Validierungen
- (1)
Kat. Nr.
ABIN7198809
Menge
100 μg
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN7198810
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Source
Escherichia coli (E. coli)
Validierungen
Kat. Nr.
ABIN7519575
Menge
1 mg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren MERS-CoV Nucleocapsid Produkten
: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991): "Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus." in: Scientific reports, Vol. 10, Issue 1, pp. 7257, (2020) (PubMed).
: "Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV." in: Viruses, Vol. 11, Issue 1, (2019) (PubMed).
: "Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus." in: Emerging microbes & infections, Vol. 7, Issue 1, pp. 60, (2018) (PubMed).
: "Comparative pathology of rhesus macaque and common marmoset animal models with Middle East respiratory syndrome coronavirus." in: PLoS ONE, Vol. 12, Issue 2, pp. e0172093, (2017) (PubMed).
: "The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection." in: Vaccine, Vol. 35, Issue 1, pp. 10-18, (2016) (PubMed).
: "Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge." in: EBioMedicine, Vol. 2, Issue 10, pp. 1438-46, (2016) (PubMed).
Haben Sie etwas anderes gesucht?
- MERS-CoV
- MERS-Coronavirus Spike
- Merlin
- MERD
- Meprin B
- MEPE
- MEPCE
- MEP1A
- MEOX2
- MEOX1
- Meningioma 1
- Menin
- MEND
- menC
- MEMO1
- Membrane-Spanning 4-Domains, Subfamily A, Member 8
- Membrane transport protein XK
- Membrane Protein, Palmitoylated 2 (MAGUK P55 Subfamily Member 2)
- Membrane IgA
- Membralin
- MERTK
- MerTK/Tyro3
- MESDC1
- MESDC2
- Mesogenin 1
- Mesothelin
- Mesothelin (Amatuximab Biosimilar)
- MESP1
- Mesp2
- MEST
- MET
- MET14
- MET6
- MET8
- Meta-Pneumovirus
- Metabotropic Glutamate Receptor 1
- Metabotropic Glutamate Receptor 3
- Metabotropic Glutamate Receptor 4
- Metabotropic Glutamate Receptor 5
- Metabotropic Glutamate Receptor 6
Sie sind hier:
